NVision
About NVision
NVision was established as a spin-off from the University of Ulm’s Institute of Quantum Optics and Institute of Theoretical Physics, leveraging nitrogen-vacancy centers in diamond for quantum sensing applications in medical imaging. Founded by Prof. Fedor Jelezko, Prof. Martin Plenio, Prof. Alex Retzker, and Ilai Schwartz (CTO), with Dr. Sella Brosh serving as CEO. The company raised $30 million Series A in June 2023 to deploy quantum-powered hyperpolarizers for MRI imaging, enabling earlier cancer treatment assessment. NVision’s technology fundamentally changes medical MRI by dramatically improving sensitivity through dynamic nuclear polarization using NV centers in diamond. The company bridges quantum physics and clinical medicine.
2025 Developments: The company continues to advance its quantum hardware capabilities throughout 2025. Ongoing research and development efforts focus on improving qubit performance and scalability. The organization maintains active collaboration with research institutions and industry partners.
Company Information
- Founded: 2015
- Country: Germany
- Website: https://www.nvision-imaging.com
- Categories: hardware, diamond, quantum sensing
Key People
Sella Brosh (CEO), Ilai Schwartz (CTO, Co-founder), Fedor Jelezko (Co-founder), Martin Plenio (Co-founder), Alex Retzker (Co-founder)
Related Companies
Explore other quantum computing companies in similar categories or regions.